Clay Cockerell, MD
Dermatopathology · Dallas, TXNPI 1235119298
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Almirall LLC at 40.6% of the total. Among dermatopathology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 111 payments — averaging $356.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Almirall LLC$16K
- Merck$10K
- Stemline Therapeutics Inc.$4K
- Blueprint Medicines Corporation$3K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$635
- Arcutis Biotherapeutics, Inc.$548
- plus $5K from 22 others
What the payments were for
- Consulting fees$22,72057%
- Speaking & faculty fees$7,99520%
- Travel & lodging$1,6034%
- Food & beverage$7,23918%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Almirall LLC | 12 | $16,045 |
| Merck | 10 | $10,193 |
| Stemline Therapeutics Inc. | 3 | $3,825 |
| Blueprint Medicines Corporation | 2 | $2,999 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $635 |
| Arcutis Biotherapeutics, Inc. | 6 | $548 |
| Regeneron Healthcare Solutions, Inc. | 4 | $475 |
| Boehringer Ingelheim | 4 | $468 |
| Sanofi | 4 | $461 |
| Novartis | 5 | $419 |
| Sun Pharmaceutical Industries Inc. | 9 | $335 |
| E.r. Squibb & Sons, L.L.C. | 3 | $288 |
| LEO Pharma Inc. | 12 | $282 |
| Incyte Corporation | 4 | $281 |
| Dermavant Sciences, Inc. | 2 | $271 |
| Johnson & Johnson | 2 | $267 |
| UCB, Inc. | 3 | $253 |
| Sensus Healthcare, Inc. | 2 | $252 |
| Lilly USA, LLC | 4 | $241 |
| Galderma Laboratories, L.p. | 2 | $150 |
| Janssen Scientific Affairs, LLC | 1 | $146 |
| Biofrontera Inc. | 2 | $141 |
| AbbVie | 2 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $119 |
| Amgen | 1 | $108 |
| Pfizer | 1 | $107 |
| Kyowa Kirin, Inc. | 1 | $92 |
| EPI Health, LLC | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$39,558 in reported general payments places this provider in the 90th percentile of 54 dermatopathology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spinosad | 13 | $36,984 |
| Malathion | 13 | $18,408 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Dallas
- Titilola SodeDallas$11K
- John WoffordDallas$11K
- Gregory HoslerDallas$3K
- Joseph SusaDallas$470
- Robert LawDallas$68
- Ryan HickDallas$50
- Angela MooreArlington$423K
- Melissa ChiangSpring$163K
- Alde GavinoLiberty Hill$110K
- Michael TetzlaffHoustion$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.